Immunocore reports Phase I/II data for uveal melanoma candidate

Immunocore Ltd. (Abingdon, U.K.) reported data from 19 evaluable patients with metastatic uveal melanoma in the Phase I portion of the Phase

Read the full 228 word article

User Sign In